Your browser doesn't support javascript.
loading
Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model.
Kaneko, Yoko; Fukahori, Hidehiko; Yamagami, Kaoru; Kawashima, Tomoko; Ito, Misato; Akamatsu, Masahiko; Marui, Takanori; Kato, Koji; Takahashi, Fumie; Morokata, Tatsuaki.
Afiliação
  • Kaneko Y; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan. Electronic address: yoko.kaneko@astellas.com.
  • Fukahori H; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Yamagami K; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Kawashima T; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Ito M; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Akamatsu M; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Marui T; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Kato K; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Takahashi F; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Morokata T; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
Int Immunopharmacol ; 87: 106764, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32736191

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Classe I de Fosfatidilinositol 3-Quinases Limite: Animals Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Classe I de Fosfatidilinositol 3-Quinases Limite: Animals Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2020 Tipo de documento: Article